Oxidative pathways for catecholamines in the genesis of neuromelanin and cytotoxic quinones.
about
Computational systems analysis of dopamine metabolismThe role of oxidative stress in Parkinson's diseaseNuclear transport, oxidative stress, and neurodegenerationTranscriptional mutagenesis by 8-oxodG in α-synuclein aggregation and the pathogenesis of Parkinson's diseaseCatecholamine autotoxicity. Implications for pharmacology and therapeutics of Parkinson disease and related disordersAltered energy production, lowered antioxidant potential, and inflammatory processes mediate CNS damage associated with abuse of the psychostimulants MDMA and methamphetamineMetals, oxidative stress and neurodegeneration: a focus on iron, manganese and mercuryNovel (Hetero)arylalkenyl propargylamine compounds are protective in toxin-induced models of Parkinson's diseasePerturbations in dopamine synthesis lead to discrete physiological effects and impact oxidative stress response in Drosophila.Serotonin 1A Receptors on Astrocytes as a Potential Target for the Treatment of Parkinson's DiseaseChanges in endoplasmic reticulum stress proteins and aldolase A in cells exposed to dopamineDisease-toxicant interactions in Parkinson's disease neuropathologyNeurotoxicity of methamphetamine and 3,4-methylenedioxymethamphetamineThe Drosophila vesicular monoamine transporter reduces pesticide-induced loss of dopaminergic neurons.Re-exploration of the PHCCC Scaffold: Discovery of Improved Positive Allosteric Modulators of mGluR4Cell type-specific gene expression of midbrain dopaminergic neurons reveals molecules involved in their vulnerability and protectionHydrogen in drinking water reduces dopaminergic neuronal loss in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease.Alpha-synuclein overexpression increases dopamine toxicity in BE2-M17 cellsNonmotor symptoms of Parkinson's disease revealed in an animal model with reduced monoamine storage capacityNeuroprotective effects of anthocyanin- and proanthocyanidin-rich extracts in cellular models of Parkinson׳s disease.Antidepressant-like effect of tetrahydroisoquinoline amines in the animal model of depressive disorder induced by repeated administration of a low dose of reserpine: behavioral and neurochemical studies in the rat.Post translational changes to α-synuclein control iron and dopamine trafficking; a concept for neuron vulnerability in Parkinson's disease.Survivin mutant protects differentiated dopaminergic SK-N-SH cells against oxidative stress.Reduced antioxidant defense in early onset first-episode psychosis: a case-control study.skn-1-Dependent and -independent regulation of aip-1 expression following metabolic stress in Caenorhabditis elegans.Neuromelanin biosynthesis is driven by excess cytosolic catecholamines not accumulated by synaptic vesicles.The AS/AGU rat: a spontaneous model of disruption and degeneration in the nigrostriatal dopaminergic system.Pharmacological treatment of Parkinson's disease.Effect of single amino acid substitution on oxidative modifications of the Parkinson's disease-related protein, DJ-1Early postnatal exposure to ultrafine particulate matter air pollution: persistent ventriculomegaly, neurochemical disruption, and glial activation preferentially in male mice.Methylphenidate exposure induces dopamine neuron loss and activation of microglia in the basal ganglia of mice.Neurobiological characterization of bipolar affective disorders : a focus on tardive dyskinesia and soft neurological signs in relation to serum dopamine Beta hydroxylase activity.Human SOD2 modification by dopamine quinones affects enzymatic activity by promoting its aggregation: possible implications for Parkinson's diseaseChronic L-dopa decreases serotonin neurons in a subregion of the dorsal raphe nucleusVMAT2-Deficient Mice Display Nigral and Extranigral Pathology and Motor and Nonmotor Symptoms of Parkinson's Disease.Oxidative stress and level of antioxidant enzymes in drug-naive schizophrenics.Cytokine receptor-like factor 1 (CRLF1) protects against 6-hydroxydopamine toxicity independent of the gp130/JAK signaling pathway.Characterization of reduced and oxidized dopamine and 3,4-dihydrophenylacetic acid, on brain mitochondrial electron transport chain activities.Inhibition and covalent modification of tyrosine hydroxylase by 3,4-dihydroxyphenylacetaldehyde, a toxic dopamine metabolite.Semiquinone anion radicals of catechol(amine)s, catechol estrogens, and their metal ion complexes.
P2860
Q21144295-057D3269-3AA3-407C-9096-BE8AB85B7119Q24307946-2B0C7C69-C11C-4269-898E-D561E290FA38Q24624357-043FC638-9347-4732-B3FD-AC4D107E739DQ26796502-AD9BEA4E-1C48-4719-A056-1819B73D327CQ26826093-38E81255-1C79-44D0-B85C-B0C640E07A22Q26858946-D25C7262-74E8-44E8-88A0-510BA92CF8E8Q26863224-1267AF5A-91A1-4E96-9343-3786664E769FQ27301283-59D2C5AB-B6DF-4A04-B7AC-4C9C8D182B34Q27309825-434671B8-1621-481F-A6CE-1FCE98B02950Q28079379-3BDD790D-05BF-4327-8E9A-5D0130E5561DQ28583030-D8697156-AA0F-4331-B4BB-28270E1DECCEQ29248297-E657545D-DD83-4224-A32D-0EFD3D8E0454Q30417935-193873D3-EB54-446C-9008-9C5123C74A26Q30430534-4FAF24CF-30D7-4B0A-A319-6230F6638C0DQ30475109-FC0C663A-56E7-41C5-BECB-C4C2E1D6A5EFQ31172552-78C36399-E24E-41F9-93F0-E052972BE70EQ33507513-DB0B4522-642C-43DF-A530-2D256BAF5FBBQ33545484-CEA77C81-FABE-405E-8FB2-56D0C951FA72Q33617472-2F529568-E1A7-4208-8D8E-5D878BCFBCBFQ33625539-9207C88C-61D8-4C66-A6B0-05C9BE67A3E2Q33671819-A5A834FD-B318-4DE9-9659-CF3AEE160DF8Q33776138-E0C97D6E-6475-4BE0-889C-620D39A19AF3Q33798063-0CD960A6-E049-4605-AF38-9B7316D9D324Q33820188-F63363A8-26B5-412B-825B-EFE88309FC8EQ33876975-45463082-55D7-4A38-9DC1-539DDC43A0F5Q33922930-165FB722-140F-40B2-8562-A0337444AB6AQ33989384-CF812D34-3E0B-4C72-9210-DC523B1061E6Q34048261-6211BDEC-8405-46EC-B0A0-0996513E2C4AQ34079628-2856EBE6-F6C2-4D2F-B0BF-119AA956B885Q34131563-111648BF-379D-4722-BDE3-86536FA98738Q34217427-EBE637F1-797A-452B-8F7C-511054040DDFQ34253507-28E85385-BBD9-4D6E-AEDC-E00CDF90C3AEQ34313803-E5FD25F6-3A59-496E-9E62-A62AF301D880Q34360660-892BC48D-BC8E-45CD-9A9B-522FC4C92F92Q34595165-537EC5E4-7EBD-417A-8B2C-51E9283BF22BQ34786239-6CC5C1A4-A2E2-4BFB-BB93-E694758E4B76Q34789499-6CB92911-670E-407F-AD61-0EC6D4E55CCDQ35024921-6A3E3765-8010-46D6-91A0-CAF36AA9D330Q35028427-E8AFBA5C-B55C-4660-8B34-45D636AF85CDQ35035561-D8324BBE-1EB2-499E-A028-BC31E983F871
P2860
Oxidative pathways for catecholamines in the genesis of neuromelanin and cytotoxic quinones.
description
1978 nî lūn-bûn
@nan
1978年の論文
@ja
1978年論文
@yue
1978年論文
@zh-hant
1978年論文
@zh-hk
1978年論文
@zh-mo
1978年論文
@zh-tw
1978年论文
@wuu
1978年论文
@zh
1978年论文
@zh-cn
name
Oxidative pathways for catecho ...... elanin and cytotoxic quinones.
@en
Oxidative pathways for catecho ...... elanin and cytotoxic quinones.
@nl
type
label
Oxidative pathways for catecho ...... elanin and cytotoxic quinones.
@en
Oxidative pathways for catecho ...... elanin and cytotoxic quinones.
@nl
prefLabel
Oxidative pathways for catecho ...... elanin and cytotoxic quinones.
@en
Oxidative pathways for catecho ...... elanin and cytotoxic quinones.
@nl
P1476
Oxidative pathways for catecho ...... elanin and cytotoxic quinones.
@en
P2093
P304
P577
1978-07-01T00:00:00Z